CRPFY yields 5.36% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CRPFY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRPFY + PFE for your $10,000?
Corporación Financiera Colombiana S.A. operates as a private financial institution in Columbia and Central America. It operates through Financial, Power and Gas, Infrastructure, Hospitality, Agroindustry, and Others segments. The company provides investment banking services, including merger and acquisition advisory services; capital market services, comprising issuance and placement of securities, such as bonds, securitizations, shares, commercial papers, bonds convertible into shares, etc.; and fundraising services. It also offers treasury products, consisting of legal tender, foreign currency, and investment and money market products; and commercial banking services. It also operates road concessions and hotels; produces and commercializes palm oil, palm kernel oil, palm kernel cake, technically specified rubber, certified rice seed, and bio-inputs; and manufactures synthetic fabrics, products specialized in providing shadow, and enclosure solutions under the Polisombra brand, as well as bonding and fastening media for agro-industrial and home use. In addition, the company operates 3,204 kms of gas pipeline; and distributes natural gas to approximately 3.72 million users. The company was founded in 1961 and is based in Bogotá, Colombia.
Full CRPFY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.